Women and Heart Disease > Evaluation and Prevention
Preventative Drug Interventions
| Aspirin High Risk. Unless contraindicated, aspirin therapy (75-162 mg) or clopidogrel (for patients intolerant of aspirin) should be initiated in high-risk women.54 Intermediate Risk. Aspirin therapy (75-162 mg) should be considered for intermediate-risk women whose blood pressure is controlled and for whom the benefits are likely to outweigh the risk of gastrointestinal side effects.54 B-Blockers Women who have had a myocardial infarction or have chronic ischemic syndromes should receive indefinite B-blocker therapy, unless contraindicated.54 Angiotensin-Converting Enzyme (ACE) Inhibitors Unless contraindicated, ARBs should be used in high-risk women with clinical evidence of heart failure or an ejection fraction <40% who are intolerant of ACE inhibitors.54 |
|
